Nicorette Mint Spray Buccal (Nicotine)

Nicotine, the active ingredient in Nicorette Mint Spray Buccal, is a nicotine replacement therapy presented as a buccal spray for oromucosal use. It provides a controlled dose of nicotine to adult smokers seeking to quit, helping to alleviate withdrawal symptoms and cravings associated with smoking cessation.

GNH USA supplies Nicorette Mint Spray Buccal as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, ensuring consistent quality and regulatory compliance for global distribution to meet local health authority requirements.

Nicotine, delivered via Nicorette Mint Spray Buccal, is used in nicotine replacement therapy to support smoking cessation.

- Smoking cessation: reduces withdrawal symptoms and cravings in adults attempting to quit tobacco. - Tobacco dependence: provides a controlled nicotine source to aid gradual reduction of cigarette use. - Relapse prevention: helps maintain abstinence by managing occasional urges after quitting.

Nicotine buccal spray may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Throat discomfort: transient scratchy feeling. - Nausea: occasional upset stomach. - Headache: mild to moderate intensity. - Dizziness: brief light‑headedness. - Increased salivation: temporary excess saliva.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or difficulty breathing. - Persistent hypertension: elevated blood pressure not resolving. - Cardiac arrhythmia: irregular heartbeat episodes. - Severe nausea or vomiting: prolonged gastrointestinal upset. - Respiratory distress: unexpected shortness of breath. - Local ulceration: ulcer formation at spray site.

When using Nicorette Mint Spray Buccal, consider the following safety measures.

- Contraindication: avoid use if you have a known hypersensitivity to nicotine or product excipients. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss risks with a clinician, as nicotine may be transferred via milk. - Cardiovascular disease: use under medical supervision if you have heart conditions. - Age restriction: intended for adult smokers only; not for use by minors. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Nicotine spray can interact with other substances that affect nicotine metabolism or cardiovascular function.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may amplify nicotine’s cardiovascular effects. - Beta‑blockers: increased risk of bradycardia or hypotension. - Certain antidepressants (e.g., bupropion): heightened seizure risk.

Moderate Interactions (Monitor Closely): - Caffeine‑containing products: may exacerbate jitteriness or insomnia. - Alcohol: can increase nicotine tolerance, leading to higher usage. - Antihypertensive agents: monitor blood pressure for additive lowering effects.